Statement Of Cash Flows [Abstract]

Egetis Therapeutics - Filing #701621

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
101 859 SEK
176 690 SEK
Adjustments for increase (decrease) in trade and other payables
31 333 SEK
25 624 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) decrease (increase) in restricted cash and cash equivalents
785,000 SEK
SEK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
SEK
22 130 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.